These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29655671)

  • 1. Overreporting healthcare-associated C. difficile: A comparison of NHSN LabID with clinical surveillance definitions in the era of molecular testing.
    Albert K; Ross B; Calfee DP; Simon MS
    Am J Infect Control; 2018 Sep; 46(9):998-1002. PubMed ID: 29655671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 2 Clostridium difficile surveillance methods: National Healthcare Safety Network's laboratory-identified event reporting module versus clinical infection surveillance.
    Gase KA; Haley VB; Xiong K; Van Antwerpen C; Stricof RL
    Infect Control Hosp Epidemiol; 2013 Mar; 34(3):284-90. PubMed ID: 23388363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between National Healthcare Safety Network laboratory-identified event reporting versus traditional surveillance for Clostridium difficile infection.
    Durkin MJ; Baker AW; Dicks KV; Lewis SS; Chen LF; Anderson DJ; Sexton DJ; Moehring RW
    Infect Control Hosp Epidemiol; 2015 Feb; 36(2):125-31. PubMed ID: 25632994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance and epidemiology of Clostridioides difficile infection using the national health surveillance network criteria: A 7-year study from Mumbai, India.
    Rohra S; Poojary A; Patil P; John S; Michael R; Johnson S; Pardeshi P
    Indian J Med Microbiol; 2023; 46():100425. PubMed ID: 37945118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential for the current National Healthcare Safety Network (NHSN) >3 days after admission definition of laboratory-identified, healthcare-facility-onset,
    Puri S; Hughes HY; McCrackin MD; Williford R; Gebregziabher M; Salgado CD; Curry SR
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):467-468. PubMed ID: 31973777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals.
    Zilberberg MD; Tabak YP; Sievert DM; Derby KG; Johannes RS; Sun X; McDonald LC
    Infect Control Hosp Epidemiol; 2011 Jul; 32(7):649-55. PubMed ID: 21666394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset
    Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter study of Clostridium difficile infection rates from 2000 to 2006.
    Dubberke ER; Butler AM; Yokoe DS; Mayer J; Hota B; Mangino JE; Khan YM; Popovich KJ; Fraser VJ
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1030-7. PubMed ID: 20695799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Use of the Case Mix Index for Risk Adjustment of Healthcare-Associated Infection Data: An Illustration using Clostridium difficile Infection Data from the National Healthcare Safety Network.
    Thompson ND; Edwards JR; Dudeck MA; Fridkin SK; Magill SS
    Infect Control Hosp Epidemiol; 2016 Jan; 37(1):19-25. PubMed ID: 26486597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate Clostridium difficile Testing and Consequent Overtreatment and Inaccurate Publicly Reported Metrics.
    Kelly SG; Yarrington M; Zembower TR; Sutton SH; Silkaitis C; Postelnick M; Mikolajczak A; Bolon MK
    Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1395-1400. PubMed ID: 27666285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of an electronic medical record nudge on reducing testing for hospital-onset
    Howard-Anderson JR; Sexton ME; Robichaux C; Wiley Z; Varkey JB; Suchindran S; Albrecht B; Ashley Jones K; Fridkin SK; Jacob JT
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):411-417. PubMed ID: 32036798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions.
    Lambert PJ; Dyck M; Thompson LH; Hammond GW
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):945-51. PubMed ID: 19732008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing community-associated from hospital-associated Clostridium difficile infections in children: implications for public health surveillance.
    Tschudin-Sutter S; Tamma PD; Naegeli AN; Speck KA; Milstone AM; Perl TM
    Clin Infect Dis; 2013 Dec; 57(12):1665-72. PubMed ID: 24046303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of Clostridium difficile infection surveillance systems in Europe, 2011.
    Kola A; Wiuff C; Akerlund T; van Benthem BH; Coignard B; Lyytikäinen O; Weitzel-Kage D; Suetens C; Wilcox MH; Kuijper EJ; Gastmeier P;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27469420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis.
    Demir SÖ; Kepenekli E; Akkoç G; Yakut N; Soysal A
    Turk J Pediatr; 2021; 63(6):1004-1011. PubMed ID: 35023650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to: Surveillance of Clostridium difficile infections.
    Krutova M; Kinross P; Barbut F; Hajdu A; Wilcox MH; Kuijper EJ;
    Clin Microbiol Infect; 2018 May; 24(5):469-475. PubMed ID: 29274463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric oncology and stem cell transplant patients with healthcare-associated Clostridium difficile infection were already colonized on admission.
    Al-Rawahi GN; Al-Najjar A; McDonald R; Deyell RJ; Golding GR; Brant R; Tilley P; Thomas E; Rassekh SR; O'Gorman A; Wong P; Turnham L; Dobson S
    Pediatr Blood Cancer; 2019 May; 66(5):e27604. PubMed ID: 30666782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emergence of community-onset Clostridium difficile infection in a tertiary hospital in Singapore: a cause for concern.
    Tan XQ; Verrall AJ; Jureen R; Riley TV; Collins DA; Lin RT; Balm MN; Chan D; Tambyah PA
    Int J Antimicrob Agents; 2014 Jan; 43(1):47-51. PubMed ID: 24290727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID).
    Davies K; Davis G; Barbut F; Eckert C; Petrosillo N; Wilcox MH
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1949-1956. PubMed ID: 27590621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity and frequency of community-onset Clostridium difficile infection on an Australian tertiary referral hospital campus.
    Clohessy P; Merif J; Post JJ
    Int J Infect Dis; 2014 Dec; 29():152-5. PubMed ID: 25449250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.